A Study of CRD3874-SI in People With Leukemia

NCT07661095 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

24

Enrollment

OTHER

Sponsor class

Conditions

Acute Myeloid Leukemia
AML
Refractory Acute Myeloid Leukemia

Interventions

DRUG: CRD3874-SI

Sponsor

Memorial Sloan Kettering Cancer Center